who’s in your group of major ortho companies? Zimmer by far not in the worst position.
Of the 4 im more familiar with, Zimmer Biomet is number 4.
J&J has a slew of companies outside of orthopedics.
Medtronic has multiple medical products in its portfolio outside of ortho market.
Stryker has medical & surgical equipment/Neurological products in addition to its core orthopedics products.
Heck even Smith & Nephew, which is 5th, is diversified outside of core ortho markets including wound care and Ear, Nose, Throat.
Meanwhile Zimmer Biomet is exclusively ortho which makes its the weakest of all the companies in regards to being hit by reduced demand in elective surgeries during things like pandemics. Acquiring Paragon 28 was labeled as diversification but Foot/Ankle is still within the greater orthopedics market. Zimmer Biomet absolutely needs to branch outside this core market unless it really does want to sell itself off. Ive been saying this for years and didnt think Zimmer Biomet could manage mid-digit growth. But it did by reducing its revenue and unloading Spine/Dental.
Think about the markets Sintx could bring to Zimmer Biomet. Wound Care, PPE, Air Filtration, Neural Implants, Cancer, Catheters, Biosensors, and so many others. Thats true diversification and at least half of those products are necessary regardless of the state of the world. If Zimmer Biomet and say Solventum joined forces they could sell products in several of these markets and license the rest. I suspect Solventum is partnered with Sintx as Hanson knows all about it from his ZB days. Hard to say though as Sintx partners are almost all cloaked behind NDAs.
The Future of Silicon Nitride: Biomedical Applications and Beyond